Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment
Dominick J. Angiolillo, MD, PhD, FACC*,1,*,
Esther Bernardo, BSc ,
Celia Ramírez, BSc ,
Marco A. Costa, MD, PhD, FACC*,
Manel Sabaté, MD, PhD ,
Pilar Jimenez-Quevedo, MD ,
Rosana Hernández, MD, PhD ,
Raul Moreno, MD ,
Javier Escaned, MD, PhD ,
Fernando Alfonso, MD, PhD ,
Camino Bañuelos, MD ,
Theodore A. Bass, MD, FACC*,
Carlos Macaya, MD, PhD and
Antonio Fernandez-Ortiz, MD, PhD
* Division of Cardiology, University of Florida, Shands Jacksonville, Jacksonville, Florida
Cardiovascular Institute, San Carlos University Hospital, Madrid, Spain.

View larger version (15K):
[in a new window]
|
Figure 1 Platelet aggregation after 6 and 20 µM adenosine diphosphate (ADP) stimuli in noninsulin-treated diabetes mellitus (NITDM; open bars) and insulin-treated diabetes mellitus (ITDM; solid bars).
|
|

View larger version (26K):
[in a new window]
|
Figure 2 Platelet aggregation after 6 (left) and 20 (right) µM adenosine diphosphate (ADP) stimuli in nondiabetic patients (NDM; dotted bars), noninsulin-treated diabetes mellitus (NITDM; open bars) and insulin-treated diabetes mellitus (ITDM; solid bars).
|
|
|